ARTICLE | Strategy
Hoechst's busy week
October 16, 1995 7:00 AM UTC
Noteworthy
Just days after announcing a $150 million gene therapy deal with Cell Genesys Inc. (see BioCentury Extra Oct. 11), Hoechst Marion Roussel announced two three-year genomics research agreements - potentially worth nearly $50 million - with Incyte Pharmaceuticals Inc. and Lynx Therapeutics Inc...